Different Basic Fibroblast Growth Factor and Fibroblast Growth Factor-Antisense Expression in Eutopic Endometrial Stromal Cells Derived from Women with and without Endometriosis

A Mihalich, Alessandra Mihalich, María Dolores Reina, M Reina, S Mangioni, Silvia Mangioni, E Ponti, L Alberti, Luisella Alberti, Paola Viganò, P Viganò, M Vignali, A M Di Blasio
The Journal of clinical endocrinology and metabolism · 2003 · vol. 88(6) , pp. 2853–2859 · doi:10.1210/jc.2002-021434 · PMID:12788899 · W2141442944
article OA: bronze CC0 ⤵ 19 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Endometrial stromal cells from women with endometriosis exhibited higher bFGF mRNA and protein levels along with lower antisense RNA (1B FGF-AS) mRNA compared to controls, particularly in the late proliferative phase.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In all species studied, the basic fibroblast growth factor (bFGF) gene is transcribed into multiple mRNAs, one of which is an antisense RNA (1B FGF-AS) probably involved in regulating the stability of the sense transcript. In this study we investigated whether the regulatory mechanisms of bFGF expression might be altered in endometrial stromal cells derived from women with endometriosis. bFGF and 1B FGF-AS mRNA levels were quantified in primary cultures of eutopic endometrial stromal cells derived from 29 women without endometriosis and 24 patients affected by the disease. When the data were analyzed according to the phase of the menstrual cycle, endometrial stromal cells derived from patients in the late proliferative phase showed significantly higher bFGF mRNA values and significantly lower 1B FGF-AS mRNA levels compared with control samples. Furthermore, the mean bFGF/1B FGF-AS mRNA ratio was significantly higher in endometrial stromal cells derived from patients compared with that in controls (mean +/- SEM, 2.31 +/- 0,55 and 0.77 +/- 0.14, respectively; P = 0.009). Moreover, for bFGF expression the differences existing at the mRNA level were maintained at the protein level. These findings support the hypothesis that 1B FGF-AS mRNA could regulate the expression of the sense transcript and suggest that in endometrial cells derived from patients, the presence of higher bFGF levels could improve their ability to proliferate at the ectopic site.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometrium Fibroblast Growth Factor 2 Fibroblast Growth Factor 2 Fibroblast Growth Factors Fibroblast Growth Factors Oligonucleotides, Antisense Base Sequence Base Sequence Cells, Cultured Endometriosis Endometriosis Endometrium Endometrium Female Fibroblast Growth Factor 2 Fibroblast Growth Factors Follicular Phase Humans Luteal Phase

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (47)

Cited by (19)

Source provenance

europepmc
last seen: 2026-06-24T06:10:11.469335+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:50.257867+00:00
License: CC0 · commercial use OK